UAE single-owner hospitals fell 17.6% since 2023 as global M&A rebounds in Q1 2026

Single-owner hospital licenses in the UAE's Northern Emirates dropped from 34 in 2023 to 28 in 2025, a 17.6% decline, according to MOHAP licensing data. The contraction tracks a global pattern: hospital M&A activity rebounded in Q1 2026 after a flat 2025, with acquirers shifting from distressed-asset purchases to strategic divestitures.

Deal composition changed in Q1

In 2024 and early 2025, most hospital transactions involved financially struggling sellers under creditor pressure. Q1 2026 looks different. Larger systems are voluntarily offloading facilities that no longer fit their geographic or clinical strategy. The same pattern is playing out across the US, Europe, and the Gulf.

Health Leaders Media attributes the rebound to improved operating margins at US hospitals after two years of cost restructuring. Systems that stabilized finances through 2025 now have bandwidth to pursue acquisitions, or to offload underperforming assets on their own terms.

Gulf operators are consolidating on a parallel track

Pure Health, the Abu Dhabi-based group, has absorbed 17 hospitals through acquisitions since 2021 and has signaled further regional expansion. Burjeel Holdings listed on the Abu Dhabi Securities Exchange in October 2023 at a valuation of AED 11.6 billion and has used public-market capital to fund clinic acquisitions across the Northern Emirates.

Regulatory frameworks from the Department of Health Abu Dhabi (DOH) and the Dubai Health Authority (DHA) favor scale. DHA's updated facility licensing standards, effective since January 2026, require electronic health record interoperability and clinical quality reporting. These impose fixed compliance costs that a 50-facility group can spread thin but that squeeze single-site operators hard.

Independent hospital owners in Dubai and the Northern Emirates face a familiar calculation: invest heavily in compliance infrastructure, or sell to a group that already has it.

What UAE operators should watch

Global healthcare private equity dry powder remains above $80 billion, according to Bain & Company's 2026 Global Healthcare Private Equity Report. Gulf-based sovereign wealth funds, including ADQ and Mubadala Health, have signaled continued appetite for healthcare assets in their home market. Acquirers are back, and they are shopping with clearer criteria than during the distressed-sale period.

Facilities that will command premium valuations share specific traits:

• Strong payer contracts with major insurers
• Clean compliance records under current DHA and DOH standards
• Integrated EHR systems that meet the January 2026 interoperability requirements
• Stable physician rosters with low turnover

Facilities without these will face either heavy capital expenditure or a sale at a discount.

The negotiating window for independent operators is measured in quarters, not years. Those considering a sale should begin preparing financials and compliance documentation now. Those planning to stay independent need a credible technology and quality roadmap that justifies the cost of operating solo in a market where consolidation keeps accelerating.